Sonographic Evaluation of the Single-incision Needleless (Contasure-needleless®) Mini-sling Placement to Predict Success

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

64 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-26

Study Completion Date

2019-04-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transperineal ultrasonography is gaining importance in preoperative and postoperative evaluation of the patient with urinary incontinence with allowing well detailed information about the anterior compartment.

There is little evidence that transperineal sonography can aid surgeons to predict the success or failure after mid-urethral slings.

We aimed to investigate the efficacy of sonography in mini-sling operations to predict the success or failure.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long Term Outcome Women Who Undergone Mid-urethral Sling Surgery

NCT03831217

Stress Urinary Incontinence

COMPLETED

Predictive Role of Urodynamics on Mid-urethral Sling Failure

NCT02337374

Urinary Incontinence, Stress

COMPLETED

Impact of Urethral Mobility on the Success of Sling Operations

NCT02301013

Urinary Incontinence

UNKNOWN NA

Efficacy of Mini Sling Versus Transobturator Tape in Surgical Management of Women With Stress Urinary Incontinence

NCT06334848

Stress Urinary Incontinence

NOT_YET_RECRUITING NA

Comparison of Minisling Suburethral Sling and Laparoscopic Buch Colposuspension

NCT05225168

Genuine Stress Incontinence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women who are scheduled for anti-incontinence operation due to their stress urinary incontinence will be pre- and postoperatively evaluated by transperineal and introital ultrasound.

Patients will be followed for at least 1 year.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Incontinence,Stress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

participants

Patients who are scheduled for single-incision needleless (Contasure-needleless®) mini-sling for their stress urinary incontinence. They will be assessed by Pelvic floor ultrasound

Pelvic floor ultrasound

Intervention Type DIAGNOSTIC_TEST

Pelvic floor ultrasound will include transperineal and introital ultrasound

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pelvic floor ultrasound

Pelvic floor ultrasound will include transperineal and introital ultrasound

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with clinically stress urinary incontinence
* Patients who claim that their condition severely impair their quality of life
* Patients who are failed on conservative management (life style changes and pelvic floor exercises)

Exclusion Criteria

* Patients who have unregulated diabetes mellitus (they will be included after appropriate and sustainable blood glucose regulation)
* Patients who have neurological condition that may affect the incontinence
* Patients who have psychiatric disease that may affect the subjective evaluation.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No